Showing 8,401 - 8,420 results of 26,260 for search '(( via ((a decrease) OR (we decrease)) ) OR ( i ((largest decrease) OR (larger decrease)) ))', query time: 1.01s Refine Results
  1. 8401
  2. 8402
  3. 8403
  4. 8404

    Identification of druggable small molecule antagonists of the <i>Plasmodium falciparum</i> hexose transporter PfHT and assessment of ligand access to the glucose permeation pathway... by Monique R. Heitmeier (6686069)

    Published 2019
    “…Decreased potency for WU-1 and the known endofacial ligand cytochalasin B was observed when PfHT was engineered to contain an N-terminal FLAG tag. …”
  5. 8405

    DataSheet1_Sodium–Glucose CoTransporter-2 Inhibitor Empagliflozin Ameliorates Sunitinib-Induced Cardiac Dysfunction via Regulation of AMPK–mTOR Signaling Pathway–Mediated Autophagy... by Changzhen Ren (10649432)

    Published 2021
    “…However, it is not clear whether SGLT2 inhibitors have cardiovascular benefits in patients with cancer chemotherapy–related cardiac dysfunction. We aimed to determine whether empagliflozin (EMPA), an SGLT2 inhibitor, has a protective role against sunitinib (SNT)-induced cardiac dysfunction in a mouse model.…”
  6. 8406
  7. 8407
  8. 8408
  9. 8409

    Image1_Antidiabetic Activity of Elephant Grass (Cenchrus Purpureus (Schumach.) Morrone) via Activation of PI3K/AkT Signaling Pathway, Oxidative Stress Inhibition, and Apoptosis in... by Oluwafemi Adeleke Ojo (12176981)

    Published 2022
    “…</p><p>Results: This in vitro study showed inhibitory potency of Cenchrus purpureus extract (AECPS) as compared with the positive controls. AECPS showed a gradual decrease in alloxan-induced increases in FBG, total cholesterol (TC), triglycerides (TG), low density lipoprotein (LDL-c), G6P, F-1,6-BP, malondialdehyde (MDA), IL-6, TNF-α, and NF-ĸB and increased alloxan-induced decreases in liver glycogen, hexokinase, and high density lipoprotein (HDL-c). …”
  10. 8410
  11. 8411

    Relative sensitivity to perturbations in incidence. by Kris V. Parag (4540165)

    Published 2022
    “…If epidemic size is smaller, larger relative incidence perturbations are required to detect the same change in <i>R</i><sub><i>s</i></sub> (curves have steeper gradient as we traverse from blue to red). …”
  12. 8412
  13. 8413

    Synthesis and Evaluation of Amyloid β Derived and Amyloid β Independent Enhancers of the Peroxidase-like Activity of Heme by Amelie Wißbrock (1923217)

    Published 2016
    “…In the context of Alzheimer’s disease (AD), however, decreased levels of free heme have been reported. Therefore, we were looking for an assay system that can be used for heme concentration determination. …”
  14. 8414

    Synthesis and Evaluation of Amyloid β Derived and Amyloid β Independent Enhancers of the Peroxidase-like Activity of Heme by Amelie Wißbrock (1923217)

    Published 2016
    “…In the context of Alzheimer’s disease (AD), however, decreased levels of free heme have been reported. Therefore, we were looking for an assay system that can be used for heme concentration determination. …”
  15. 8415

    Synthesis and Evaluation of Amyloid β Derived and Amyloid β Independent Enhancers of the Peroxidase-like Activity of Heme by Amelie Wißbrock (1923217)

    Published 2016
    “…In the context of Alzheimer’s disease (AD), however, decreased levels of free heme have been reported. Therefore, we were looking for an assay system that can be used for heme concentration determination. …”
  16. 8416

    Synthesis and Evaluation of Amyloid β Derived and Amyloid β Independent Enhancers of the Peroxidase-like Activity of Heme by Amelie Wißbrock (1923217)

    Published 2016
    “…In the context of Alzheimer’s disease (AD), however, decreased levels of free heme have been reported. Therefore, we were looking for an assay system that can be used for heme concentration determination. …”
  17. 8417

    Synthesis and Evaluation of Amyloid β Derived and Amyloid β Independent Enhancers of the Peroxidase-like Activity of Heme by Amelie Wißbrock (1923217)

    Published 2016
    “…In the context of Alzheimer’s disease (AD), however, decreased levels of free heme have been reported. Therefore, we were looking for an assay system that can be used for heme concentration determination. …”
  18. 8418

    Synthesis and Evaluation of Amyloid β Derived and Amyloid β Independent Enhancers of the Peroxidase-like Activity of Heme by Amelie Wißbrock (1923217)

    Published 2016
    “…In the context of Alzheimer’s disease (AD), however, decreased levels of free heme have been reported. Therefore, we were looking for an assay system that can be used for heme concentration determination. …”
  19. 8419

    Synthesis and Evaluation of Amyloid β Derived and Amyloid β Independent Enhancers of the Peroxidase-like Activity of Heme by Amelie Wißbrock (1923217)

    Published 2016
    “…In the context of Alzheimer’s disease (AD), however, decreased levels of free heme have been reported. Therefore, we were looking for an assay system that can be used for heme concentration determination. …”
  20. 8420

    Synthesis and Evaluation of Amyloid β Derived and Amyloid β Independent Enhancers of the Peroxidase-like Activity of Heme by Amelie Wißbrock (1923217)

    Published 2016
    “…In the context of Alzheimer’s disease (AD), however, decreased levels of free heme have been reported. Therefore, we were looking for an assay system that can be used for heme concentration determination. …”